deltatrials
Terminated EARLY_PHASE1 INTERVENTIONAL 2-arm NCT05841706

Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic Cancer

Open Label Randomized Trial of Blood Transfusions in Cancer Patients Following a Pancreatectomy: A Feasibility Study

Sponsor: Jonsson Comprehensive Cancer Center

Conditions Resectable Pancreatic Carcinoma
Interventions Arm I Packed Red Blood Cell Transfusion (Hgb < 7 g/dL) Arm II Packed Red Blood Cell Transfusion (Hgb < 9 g/dL) Biospecimen Collection Computed Tomography Pancreatectomy Survey Administration X-Ray Imaging
Updated 8 times since 2023 Last updated: Jun 5, 2025 Started: Aug 10, 2023 Primary completion: Mar 17, 2025 Completion: Mar 17, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

slow accrual

Other terminated trials from Jonsson Comprehensive Cancer Center

See all terminations from Jonsson Comprehensive Cancer Center

Other Resectable Pancreatic Carcinoma trials with similar outcome

Browse all Resectable Pancreatic Carcinoma trials

A EARLY_PHASE1 clinical study on Resectable Pancreatic Carcinoma, this trial is terminated or withdrawn. The trial is conducted by Jonsson Comprehensive Cancer Center and has accumulated 8 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jun 2023 – ~Sep 2023 · 3 months · monthly snapshotNot Yet Recruiting~Sep 2023 – ~Feb 2024 · 5 months · monthly snapshotNot Yet Recruiting~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshotRecruiting~Mar 2025 – ~Apr 2025 · 31 days · monthly snapshot~Apr 2025 – ~Jul 2025 · 3 months · monthly snapshotSuspended~Jul 2025 – present · 12 months · monthly snapshotTerminated

Change History

8 versions recorded

  1. Jul 2025 — Present [monthly]

    Terminated EARLY_PHASE1

    Status: Suspended → Terminated

  2. Apr 2025 — Jul 2025 [monthly]

    Suspended EARLY_PHASE1

    Status: Recruiting → Suspended

  3. Mar 2025 — Apr 2025 [monthly]

    Recruiting EARLY_PHASE1

  4. Sep 2024 — Mar 2025 [monthly]

    Recruiting EARLY_PHASE1

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting EARLY_PHASE1

▶ Show 3 earlier versions

  1. Feb 2024 — Jul 2024 [monthly]

    Recruiting EARLY_PHASE1

    Status: Not Yet Recruiting → Recruiting

  2. Sep 2023 — Feb 2024 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  3. Jun 2023 — Sep 2023 [monthly]

    Not Yet Recruiting EARLY_PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jonsson Comprehensive Cancer Center
Data source: Jonsson Comprehensive Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations